Stay updated with breaking news from Psychedelics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and effica...
The journal Nature published a new research analysis from Imperial College London (ICL)’s Center for Psychedelic Research and University of California San Francisco (UCSF)’s Psychedelics Division, including renowned David Erritzoe and Robin Carhart-Harris.
PSYCH Symposium, Europe’s leading event in psychedelic medicine, returned to London on July 6th with huge success for the second year running. Click to read more...
Approximately two-thirds of trial patients with Major Depressive Disorder achieving remission following SPL026 treatment sustained remission to six-monthsLONDON, April 04, 2023 -- Small Pharma Inc.... | April 4, 2023
Approximately two-thirds of trial patients with Major Depressive Disorder achieving remission following SPL026 treatment sustained remission to six-months...